New guidelines for treating osteoporosis in menopausal women

At the beginning of this year, The American College of Physicians (ACP) updated its guidelines for therapy to reduce the risk of fractures in adults with primary osteoporosis or osteopenia (low bone mass). It was the first update since 2017. Among other recommendations, the new guidelines strongly recommend initial therapy for postmenopausal women with osteoporosis […]

What are the most common side effects of Prolia?

Prolia® (generic name: denosumab) is prescribed for patients in danger of developing osteoporosis, usually due to the normal aging process that causes changes in bone density. Osteoporosis was previously thought to be especially prevalent in women in menopause, but it is in fact the most common metabolic bone disease in the United States, affecting both […]

What are the benefits of taking Prolia®?

Prolia® (generic name: denosumab) is a recently developed drug prescribed for a wide range of conditions of the skeletal bones, including osteoporosis, bone loss induced by radical treatments for cancer, cases where cancers have metastasized to bones, and giant cell tumors of bones. Denosumab is a human monoclonal antibody. Monoclonal antibody therapy has two main […]